Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia
NCT01388283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129
Last updated 2011-07-06
Summary
The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.
Conditions
Sponsors & Collaborators
-
Oslo University Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 43 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-01-31
- Primary Completion
- 2004-05-31
- Completion
- 2011-06-30
More Related Trials
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Preeclampsia and Circulating Biomarkers
NCT02136667 ·Status: UNKNOWN
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
NCT02337049 ·Status: UNKNOWN
-
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500 ·Status: COMPLETED
-
sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia
NCT05228002 ·Status: COMPLETED ·Phase: NA
-
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
NCT05131282 ·Status: COMPLETED
-
Biological Changes Associated With High Risk of Preeclampsia in Nulliparous Women
NCT06200571 ·Status: ENROLLING_BY_INVITATION
-
The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
NCT01856387 ·Status: UNKNOWN
-
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT03630276 ·Status: UNKNOWN ·Phase: NA
-
Micro Array Analysis in Preeclampsia
NCT01914809 ·Status: UNKNOWN ·Phase: NA
-
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
NCT01195441 ·Status: COMPLETED
-
Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia
NCT07349277 ·Status: RECRUITING
-
Study of Coagulation Activation Markers and Pre Eclampsia
NCT01261351 ·Status: COMPLETED
-
Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker
NCT06873737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations
NCT01649128 ·Status: COMPLETED
-
Biomarkers and Preeclampsia Outcomes
NCT03801447 ·Status: COMPLETED
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome
NCT03100084 ·Status: UNKNOWN
-
Aspirin and Neutrophils in Preeclampsia
NCT04974892 ·Status: COMPLETED
-
A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia
NCT00403572 ·Status: COMPLETED
-
Immunomodulation During Pregnancy
NCT06882850 ·Status: RECRUITING
-
Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
NCT01821053 ·Status: COMPLETED